Potential Salivary Markers for Differential Diagnosis of Crohn's Disease and Ulcerative Colitis.

Crohn’s disease TNF-α biomarkers calprotectin differential diagnosis inflammatory bowel disease myeloperoxidase oral immunity saliva ulcerative colitis

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
09 Sep 2021
Historique:
received: 05 08 2021
revised: 19 08 2021
accepted: 08 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 29 9 2021
Statut: epublish

Résumé

The properties of the saliva of patients with inflammatory bowel disease (IBD) are poorly recognized. Likewise, the diagnostic potential of saliva for differentiating various forms of IBD is largely unexplored. Therefore, we compared the concentrations of several parameters in unstimulated whole mixed saliva collected in a standardized manner from patients with active IBD unresponsive to conventional therapy. The samples were received from 27 patients with Crohn's disease (CD), 24 patients with ulcerative colitis (UC), and 51 healthy individuals. Compared to the controls, the salivary concentrations of S100A8/calprotectin, myeloperoxidase, and IgA were significantly decreased in both CD and UC patients. In addition, patients with UC had decreased levels of TNF-R1 and decreased catalase activity. Interestingly, the concentrations of myeloperoxidase and TNF-R1 showed a high differentiation potential for CD and UC (AUC = 0.690 and 0.672, respectively). All these findings are discussed in the context of host defense in the oral cavity, patients' prior treatment regimens, and smoking habits.

Identifiants

pubmed: 34575091
pii: life11090943
doi: 10.3390/life11090943
pmc: PMC8469159
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Int J Mol Sci. 2020 Oct 10;21(20):
pubmed: 33050496
Inflamm Bowel Dis. 2007 Jun;13(6):727-32
pubmed: 17260368
Dent Clin North Am. 2011 Jan;55(1):159-78
pubmed: 21094724
Pol Arch Med Wewn. 2012;122(5):200-8
pubmed: 22538761
Inflamm Bowel Dis. 2012 Dec;18(12):2218-24
pubmed: 22344983
Arch Oral Biol. 2019 Nov;107:104528
pubmed: 31442931
Front Immunol. 2018 Jan 30;9:74
pubmed: 29441064
Am J Gastroenterol. 2010 Mar;105(3):501-23; quiz 524
pubmed: 20068560
Pol Arch Intern Med. 2020 Apr 30;130(4):297-303
pubmed: 32041925
Ann N Y Acad Sci. 1993 Sep 20;694:72-7
pubmed: 8215087
Gastroenterology. 2000 Jul;119(1):15-22
pubmed: 10889150
DNA Res. 2014 Feb;21(1):15-25
pubmed: 24013298
J Periodontol. 2020 Oct;91(10):1274-1283
pubmed: 32052441
J Physiol Pharmacol. 2016 Oct;67(5):709-715
pubmed: 28011951
BMC Immunol. 2015 Feb 10;16:5
pubmed: 25886994
Basic Clin Pharmacol Toxicol. 2019 Nov;125(5):474-483
pubmed: 31219219
Oral Dis. 2021 Mar;27(2):280-289
pubmed: 32643850
J Oral Rehabil. 2018 Sep;45(9):730-746
pubmed: 29878444
Clin Exp Immunol. 2004 Mar;135(3):483-9
pubmed: 15008983
Pol Arch Intern Med. 2018 Jun 30;128(6):362-370
pubmed: 29806822
J Crohns Colitis. 2017 Jan;11(1):3-25
pubmed: 27660341
Tob Induc Dis. 2021 Jun 29;19:56
pubmed: 34239408
J Crohns Colitis. 2017 Feb;11(2):135-149
pubmed: 27660342
J Crohns Colitis. 2017 Jul 1;11(7):769-784
pubmed: 28513805
Arch Biochem Biophys. 2006 Jan 15;445(2):261-8
pubmed: 16111647
Dig Dis Sci. 2004 Nov-Dec;49(11-12):1752-7
pubmed: 15628697
Dent Med Probl. 2020 Apr-Jun;57(2):145-148
pubmed: 32602271
Scand J Gastroenterol. 2005 Dec;40(12):1444-8
pubmed: 16316893
Biol Trace Elem Res. 2017 Jun;177(2):235-240
pubmed: 27864666
J Crohns Colitis. 2017 Jun 1;11(6):649-670
pubmed: 28158501
Arch Immunol Ther Exp (Warsz). 1998;46(3):143-55
pubmed: 9704146
Ir J Med Sci. 1999 Jan-Mar;168(1):33-5
pubmed: 10098341
Dermatol Ther. 2019 Mar;32(2):e12811
pubmed: 30620119
Cytokine. 2018 Oct;110:174-180
pubmed: 29763839
Ann N Y Acad Sci. 2006 Dec;1091:110-22
pubmed: 17341608
Lancet. 2018 Dec 23;390(10114):2769-2778
pubmed: 29050646
Am J Clin Nutr. 2001 Aug;74(2):259-64
pubmed: 11470730
Pol Arch Med Wewn. 2012;122(12):616-23
pubmed: 23160117
Infect Immun. 2021 Sep 16;89(10):e0012221
pubmed: 34097505
Curr Med Res Opin. 2020 Sep;36(9):1457-1463
pubmed: 32573307

Auteurs

Kacper Nijakowski (K)

Department of Conservative Dentistry and Endodontics, Poznan University of Medical Sciences, 60-812 Poznan, Poland.

Rafał Rutkowski (R)

Department of Pathophysiology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.

Piotr Eder (P)

Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 60-355 Poznan, Poland.

Marek Simon (M)

Department of Pathophysiology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.

Katarzyna Korybalska (K)

Department of Pathophysiology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.

Janusz Witowski (J)

Department of Pathophysiology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.

Anna Surdacka (A)

Department of Conservative Dentistry and Endodontics, Poznan University of Medical Sciences, 60-812 Poznan, Poland.

Classifications MeSH